Archive


Category: data

  • Deep diving into a successful healthcare revenue cycle flowchart

    An efficient revenue cycle management (RCM) system is a win-win for patients and providers. Friction-free solutions that cover everything from booking appointments to paying bills create a more satisfying patient experience and allow patients to focus on their health. Providers can lower administrative costs and generate more revenue from data-driven billing and collections operations. To […]

  • Healthcare data: the value of historical patient data

    Healthcare data is mushrooming. Each patient generates hundreds of megabytes of data each year, from electronic medical records to activity logs on fitness trackers. The volume of data and diversity of sources is growing exponentially, churning out a wealth of information about patients’ medical histories, socio-economic circumstances, consumer preferences and lifestyles. This is a gold […]

  • Using digital patient payment solutions to expedite healthcare collections

    According to Jason Considine, Chief Commercial Officer at Experian Health, mounting financial pressure on consumers could lead to more patients missing healthcare payments. “Federal aid packages are being unwound, the country’s opening back up so people are spending money on things they weren’t spending money on before, and to compound that problem, we have inflation […]

  • Using technology to reassess the clinical trial landscape

    Josh Sackman, president and co-founder of AppliedVR, and Web Sun, president and co-founder of Komodo Health, relay how their newly formed collaboration reshapes the clinical trial process by using data, helping to cut costs and allowing for evaluation of broader patient populations.   AppliedVR and Komodo Health are collaborating to perform a clinical trial using the […]

  • Find your inner data and take precision marketing to the next level

    Data is the powerhouse of the pharmaceutical sector. It powers drug discovery, clinical trials, and operational performance. But sizeable reservoirs of data remain unseen and untapped to commercial operations, allowing insights, opportunities, and efficiencies to leak away. Organisations are missing out on the ability to harness their data to energise precision marketing and transform commercial […]

  • Joined up thinking needed for joined up data plans

    Joined up data could transform the pharmaceutical industry and help create a healthier Europe for decades to come – but the route to change is far from smooth sailing. Without careful consideration and full stakeholder input, the EU’s plans for a connected data system could end up being counterproductive. That’s the view of the European […]

  • Unlocking the potential of healthcare data in research

    Health data research in the UK is rapidly evolving, with new capabilities emerging through the rise of hybrid engagement and the accelerated adoption of digital technologies. At the height of the COVID-19 pandemic, these capabilities were put to the test, being used to compare hospital caseloads to research activity in real-time and enabling COVID-19 clinical […]

  • The Sovereignty Network will help patients make money out of your health data

    By HAMISH MACDONALD  Being a patient has always meant being at the bottom of a trickle-down pyramid in healthcare. Late to get information, our test results, our data, and as for earning the money that our healthcare data is worth – that is something the healthcare industry does without our permission or dues. We are […]

  • How to map HCPCS codes to meaningful procedure categories

    In order for health care providers to be reimbursed for the services they provide, they need to input a variety of information into health insurance claims systems including what type of services were performed. The codes used to define the services provided are Current Procedural Terminology (CPT) or Healthcare Common Procedure Coding System (HCPCS) codes. […]

  • Elsevier and LG: Turning data into action

    There are life-changing insights waiting to be found in chemistry data. The critical information waiting to be unlocked can lead to incredible technology advances and medical breakthroughs. But there is so much data out there, and it is multiplying rapidly. At Elsevier, we are excited about a new partnership with world-renowned innovator LG that we […]

  • Success at a glance: Patient matching to support community outreach during COVID-19

    During the COVID-19 pandemic, national and state health departments needed timely and accurate patient data to communicate quickly with citizens and make decisions about the local public health response. With support from Experian Health, the Council of State and Territorial Epidemiologists (CSTE) utilized Universal Identity Manager to provide members with reliable and accessible data tools […]

  • Innovation across the healthcare system is needed to realise the value of medicines

    Janssen’s Catherine Taylor, vice-president, EMEA medical affairs, therapy area strategy, discusses the importance of systemic innovation across the healthcare system to realise the full value of medicines. Medicines and vaccines are among the most powerful interventions that can help improve quality of life for people across the world. As an oncology trained medical doctor who […]

  • A data company is cementing its place in medical XR

    Rani Aravamudhan, MD, senior clinical consultant, and Jason Elliott, head of employer client experiences at Health Data & Management Solutions (HDMS), tell us how the company looks to leverage immersive technology and employ data to improve healthcare solutions. At the International Virtual Reality Healthcare Association (IVRHA) conference in early March, Elliott and Aravamudhan relayed how […]

  • Big data and how it can change the game in pharma: the pharmaphorum podcast

    In the latest episode of the pharmaphorum podcast, editor in chief Jonah Comstock speaks with Miruna Sasu, chief strategy officer of COTA and long-time pharma vet– before joining COTA last year, she headed up J&J’s Clinical Trial Feasibility and Advanced Analytics Team and led the Digital Health and Innovation Team at Bristol Myers Squibb. Now […]

  • Umesh Nandal: Chemist and data scientist in one

    Umesh Nandal is a Director of Data Science at Elsevier. As an AI expert with a Master’s in Chemistry, he embodies what Elsevier brings to the table – an actionable fusion of data and domain expertise. “Cross-functional teams combining data science, tech and domain knowledge is the only way we can achieve our collective goal: […]

  • 6 strategies on how to increase outpatient revenue

    Clinical advances, consumer demand and payer pressure are driving growth in outpatient care, which continues to attract attention as a lower-risk, lower-cost revenue stream for healthcare providers. New technologies allow for less invasive procedures and quicker recovery times, so patients can avoid lengthy hospital stays – and the higher out-of-pocket costs that come with them. […]

  • Solving the patient identity problem with universal identifiers

    Solving the patient identity problem and ensuring that each patient record is accurate and airtight is a top priority. Healthcare providers want to be 100% confident in answering “yes” to the following questions: Is the patient who they say they are? Is the right medication being administered to the right person? Is the correct bill […]

  • H1 acquires Faculty Opinions to grow its global expert network

    Faculty Opinions brings together the comments and opinions of thousands of top researchers in life sciences and medicine. Combined with H1’s extensive intel on healthcare providers, the acquisition expands H1’s reach and opportunity to impact healthcare by bringing this data under one umbrella, H1 CEO Ariel Katz said.

  • Revenue cycle management checklist: improve experience & profits

    Traditional revenue cycle management strategies are on shaky ground. Time-consuming manual processes are struggling under the burden of increasing patient volumes and patient financial responsibility. Clunky interfaces and disjointed systems fall short of evolving consumer expectations. Understanding and adapting to sweeping regulatory change is challenging for understaffed teams. On top of all of that, the […]

  • Better care starts with better patient identity management

    No healthcare organization is immune to the problem of bad data. One in five patients has found errors when looking at their electronic health record (EHR). This includes incorrect information about their diagnosis, medications, test results and more. If the data held in patient records is incomplete, inconsistent, or inaccurate, this can lead to poor […]

  • Utilising real-time data to improve customer engagement

    Oskar Möbert, Vice President OpenData Europe at Veeva Systems, tells us how they are reimagining customer reference data to boost pharma rep productivity, enable more personalised engagement, and increase patient reach. The medical landscape is generally becoming more complex, both in terms of the range of stakeholders involved in patient care and the rapid explosion […]

  • Content metrics help generate compelling communication

    Companies seek efficiency and speed to market during the content creation process, review and approval cycles, and thus the collective time for content to be approved for distribution, says Ian Hale, vice president of commercial content at Veeva Systems. Gathering content metrics is key to ensuring superior performance during each step. ‘’Content metrics is the […]

  • The power of similarities to accelerate antiviral development for COVID-19

    In April 2020, I wrote a blog post entitled “Exploiting similarities between SARS-CoV-2 and other viruses to accelerate vaccine and therapy development,” where I described research areas leveraging genetic and phenotypic similarities between SARS-CoV-2 and other known viruses. In my quest to find relevant data, I used Reaxys Medicinal Chemistry to generate a list of […]

  • Leveraging augmented analytics to drive better business decisions

    In early 2020, health officials were cautious about forecasting a COVID-19 vaccine timeline to the public, as vaccine discovery was a historically laborious process that took years (if not decades). Yet a successful COVID-19 vaccine gained emergency approval in just 11 months, a blistering pace that likely saved millions of lives. Such a fast turnaround […]

  • Preparing for Omicron: streamlining care with digital scheduling tools

    The recent discovery of the Omicron variant has placed the world on high alert. As COVID-19 continues to transform and evolve, erupting as “new” pandemics within the existing pandemic,  it is becoming clear that digitally-enabled clinical care and access to that care are some of the world’s tools to mitigate its spread. Should infection rates […]

  • DNA Storage in a Yottabyte Era

    By KIM BELLARD Did you know we are living in the Zettabyte Era? Honestly, did you even know what a zettabyte is? Kilobytes, gigabytes, maybe even terabytes, sure, but zettabytes? Well, if you ran data centers you’d know, and you’d care because demand for data storage is skyrocketing (all those TikTok videos and Netflix shows […]

  • What does the connected generation (Gen C) expect from providers?

    As the digital healthcare revolution takes hold, do assumptions about a generation gap still hold true? Do Millennials and Gen Z have different expectations of healthcare providers compared to Baby Boomers and Gen X? In today’s hyper-connected world, the differences are a matter of degree. We’re all Gen C now. Futurist Brian Solis coined the […]

  • Expert Q+A: how top providers are using digital patient recruitment tools

    Mass relocations during the pandemic caused seismic shifts in healthcare markets. With millions of Americans moving and reshuffling to be closer to family or take advantage of remote working opportunities, healthcare providers have extra work on their hands to ensure their patient base holds steady. Some attrition is inevitable; however, as more patients relocate, providers […]

  • Expert Q+A: how to optimize patient collections in 2022

    A little over a year ago, Experian Health surveyed healthcare providers for a snapshot of their views on the digitalization of patient access, and the importance of healthcare collections. At the start of the COVID-19 pandemic, patient collections emerged as a top priority, the result of rising unemployment and competing consumer demands that impeded patients’ […]

  • Q+A: how providers are using data and automation to optimize healthcare collections in 2022

    A little over a year ago, Experian Health surveyed healthcare providers for a snapshot of their views on the digitalization of patient access, and the importance of healthcare collections. At the start of the COVID-19 pandemic, patient collections emerged as a top priority, the result of rising unemployment and competing consumer demands that impeded patients’ […]

  • Getting a holistic picture of patients with social determinants of health

    This is the fifth in a series of blog posts that will highlight how the patient journey has evolved since the onset of COVID-19. This series will take you through the changes that impacted every step of the patient journey and provide strategic recommendations to move forward. In this post, explore the fifth step—treatment, and […]

  • Use of digital tools for clinical trials triples during pandemic; survey

    A new poll of clinical trial sponsors has found that around nine out of 10 of them are running decentralised trials with the help of digital technologies, a big increase on pre-COVID-19 levels. The survey by Veeva Systems found a big increase in the adoption of technologies that enabled remote trials during COVID-19, with increased […]

  • The Post-COVID-19 Patient Journey: What’s next for healthcare?

    COVID-19 transformed the patient journey, and it’s clear when we evaluate every step. Data and technology gave patients the convenience, flexibility, and control to get care on their terms, and these changes will be here to stay. From marketing to scheduling to payments and more – providers and payers have ample opportunities to respond to […]

  • Data dive finds cheap diuretic could be Alzheimer’s drug

    A data-mining study conducted by researchers in the US has found that an already-approved diuretic drug could have potential as a treatment for some patients with Alzheimer’s disease. The research by a team of National Institutes of Health (NIH) scientists found that people who took bumetanide, a generic drug usually used to treat heart failure […]

  • Virtual care is here to stay, but providers need to make the experience more seamless

    At a recent panel discussion, healthcare executives agreed that telehealth will remain an important part of care delivery post-pandemic, so now is the time for providers to figure out how best to incorporate these services alongside in-person care. Actionable data will prove to be a key resource for providers as they tweak their strategies.

  • COVID-19 Highlights an Acute Need for Digital Patient Intake Solutions

    This is the third in a series of blog posts highlighting how the patient journey has evolved since the onset of COVID-19. Explore how digital patient intake solutions are transforming the registration process – presenting patients with self-service options and providers with an automated and more efficient process. To read the full white paper, download […]

  • Novartis’ Amit Nastik on COVID’s supply chain impact: the pharmaphorum podcast

    Episode 41 of the pharmaphorum podcast heard from Amit Nastik about the impact of COVID-19 on pharma supply chains and how he and his team mitigated disruption to Novartis’ own operations. Amit’s the global head strategy and operations and local markets manufacturing at Novartis Technical Operations and discussed how his company ensured an uninterrupted supply […]

  • Healthcare Data Breach: What it Means for Companies and the Consumer?

    Data and analytics today are playing a major role in the organization’s growth. Stakeholders in a business environment such as companies, investors, and individuals deal with some or other kind of data in their day-to-day life. The data is key to the business prediction that helps to analyze consumer behavior. Companies stores a large amount […]

  • Patient Self-Scheduling as a Competitive Advantage – Interview with the Expert

    The rising popularity of virtual care seems to be extending itself into other areas of patient experience, including a re-energized consumer preference for digital self-scheduling. In fact, McKinsey & Company reports that telehealth visits and utilization are 38x higher than pre-COVID-19 levels (July 2021). Meanwhile, Experian Health’s State of Patient Access 2.0 survey, released in […]

  • How 24/7 self-scheduling can improve the post-pandemic patient experience

    This is the second in a series of blog posts that will highlight how the patient journey has evolved since the onset of COVID-19. This series will take you through the changes that impacted every step of the patient journey and provide strategic recommendations to move forward. In this post, we explore how 24/7 self-scheduling can […]

  • How COVID-19 changed the patient journey: A call for digital transformation

    COVID-19 changed every aspect of the patient journey – placing unprecedented demands on the healthcare system and accelerating the need for digital transformation industry-wide. Telehealth, touchless engagement, and self-service scheduling became the new normal; however, this created new stress on operations, administration, and finance. While this new normal comes with many challenges, data and digital […]

  • How data standardization can improve patient outcomes

    Patchy patient data has plagued the healthcare industry for decades, but the pandemic opened the door to a whole new set of identity management challenges. As patients rushed to register for patient portals and book vaccines, many unwittingly created multiple accounts, having forgotten they’d already signed up. Fluctuating unemployment levels meant many individuals were forced […]

  • The State of Patient Access 2.0: 4 opportunities to strengthen the digital experience

    “93% of providers say creating a better patient experience remains a top priority, up 3% from last year.” – Experian Health’s State of Patient Access, June 2021 Download now In November 2020, we surveyed patients and providers for their sentiments on how patient access changed because of the pandemic. During this time, patients welcomed the […]

  • Accelerating synthetic chemistry with a predictive retrosynthesis solution

    In most aspects of life, we think of “endless possibilities” as a good thing. But in science, the wealth of possibilities can be daunting. Pharmaceutical researchers typically start with a disease that they want to tackle, find a target, and then try to identify compounds which interact with that target. There may be around 200-300 […]

  • Widespread use of health IT can cause burnout but also help curb it

    In a HIMSS 21 Digital session, panelists detailed the dichotomy of technology advancement for clinicians. Though technology has made it harder for them to disconnect from work leading to burnout, IT tools can also be used to identify pain points and implement solutions to alleviate stress.

  • Boost vaccination rates with frictionless self-scheduling

    It’s time to accelerate the pace of COVID-19 vaccinations. Healthcare experts are increasingly concerned about the rapid spread of the highly contagious delta variant, which now makes up over 83% of COVID-19 cases. This variant is estimated to be 60% more transmissible than previous strains, and while vaccination doesn’t eliminate the risk, it does reduce […]

  • Boost vaccination rates with frictionless self-scheduling

    As the country strives to ramp up the pace of COVID-19 vaccinations, providers need to take new approaches to drive registration volume. Healthcare experts are increasingly concerned about the rapid spread of the highly contagious delta variant, which now makes up over 83% of COVID-19 cases. This variant is estimated to be 60% more transmissible […]

  • Self-service patient registration isn’t just for the pandemic

    Consumer-led care hit its stride during the pandemic. COVID-19 unlocked healthcare’s digital front door, giving patients more control over how and when they schedule and manage appointments. Unfortunately, while digital patient access has made navigating the healthcare system more convenient and flexible in many ways, consumers are discovering that one of the more frustrating aspects […]

  • Confronting the Problem of AI Bias

    When thinking of artificial intelligence (AI), many people rely on cultural touchstones from science fiction films and TV. They might think of HAL, the calm-voiced AI from 2001: A Space Odyssey, or Data, the even-tempered android from Star Trek. We tend to imagine that artificial intelligence will be driven by reason, logic and facts – […]

  • UPMC spins out AI-driven analytics company focused on chronic disease patients

    Realyze Intelligence, incubated at and funded by UPMC Enterprises, provides a platform that uses EMR data to identify chronic disease patients and help clinicians link them to appropriate treatment options. The platform leverages not only the structured data available in EMRs but also unstructured clinical notes.

  • Anthem, Epic strike data exchange partnership

    The EHR giant will integrate its payer platform with the insurer’s operating system to facilitate two-way data exchange with providers. Through this integration, the organizations hope to support clinical decision-making and streamline administrative processes like prior authorizations.

  • Key insights for a successful first-time product launch

    Pre-commercial & Emerging pharma companies may not think they have the resources to match the launch strategies of big pharma. But with the proper planning and an agile approach, they can be more successful than they realise, says Veeva’s Ian Hale. He takes us through the challenges of a successful launch and explains what pre-commercial […]

  • Guidance on use of real-world evidence for devices and diagnostics

    Real-world evidence is often used to assess the safety of devices and diagnostics. For instance, the FDA’s , Postmarketing Surveillance Program includes the FDA Adverse Event Reporting System (FAERS); FDA may also require some MedTech companies to conduct Post-Approval Studies. However, as new legislation (e.g., 21st Century Cures Act) has passed and new technology has […]

  • Jean Drouin, Clarify Health, on the new data stack.

    By MATTHEW HOLT Clarify Health has linked (but anonymized) data on about 300m Americans, including their claims, lab, (some) EMR data and their SDOH data. They then use it to help providers, plans and pharma figure out what is going on with their patients, and how their doctors et al are behaving. CEO Jean Drouin, […]

  • FDA Introduces Data Modernization Action Plan

    One of the frustrations of our Big Data era is that, despite the existence of an ever-growing wealth of valuable data, this data is often stuck in different silos. This lack of accessibility makes it hard to get the most out of data that has the potential to be extremely useful. The United States really […]

  • Life sciences must become cloud-first to seize the science of tomorrow

    If the power of the life sciences industry to innovate and collaborate were ever in doubt, the speed at which vaccines for COVID-19 were discovered, developed, trialled, approved and manufactured have confirmed just how dynamic the industry can be. And that dynamism, innovation and collaboration are all qualities that the industry must continue to nurture […]

  • Your Health Data May Be a NFT

    By KIM BELLARD I must admit, after I wrote about digital currency last week, I did not expect to be writing about crypto anytime soon. Then I heard about “non-fungible tokens” (NFTs) and got a sense of the hype they were causing — how I could I resist? There may even be a connection to […]

  • Use of real-world evidence for regulatory decision-making

    How do you evaluate treatment efficacy and safety outside of the clinical trial setting? This is not just a question of academic interest. In last week’s JAMA, Rubin 2021 writes about some of the challenges of evaluating COVID-19 vaccines outside of a clinical trial setting. In an interesting, two-day workshop last week, the Duke Margolis […]

  • 14 major health systems launch data insights company

    In an unusual move, 14 major providers — including Trinity Health, CommonSpirit Health and Tenet — have come together to launch a data analytics company. Insights derived from the company’s platform will be available to providers, biopharma companies and scientific researchers working to advance patient care.

  • Real-world evidence: breaking boundaries in rare disease

    The COVID-19 pandemic has added a new layer of complexity to the drug development process. Launch timelines have been delayed and clinical trials have been postponed or suspended. As a result, life sciences companies are turning to novel methods of collecting clinical data and innovative trial design. The generation of data to show the significant […]

  • A collaborative approach to greater diversity in clinical trials

    The need for diversity in clinical trial populations has been a topic of discussion across regulators and the industry in general for decades. Despite the introduction of US policies, beginning with the 1993 National Institutes of Health (NIH) Revitalization Act which called for the inclusion of more women and communities of colour in clinical trials, […]

  • True patient-focused research through decentralised and hybrid trials

    How can pharma improve the patient-centricity of its trials during COVID-19 and beyond? Experts from across the sector give their thoughts on the key approaches and technologies that are driving patient engagement forward. With COVID-19 presenting new barriers to running and recruiting for clinical trials, making studies patient-centric is more important now than ever before. […]

  • Elsevier to Work with Heel for Mechanism-based Drug Action Discovery

    Elsevier, the data analytics business specialized in science and health, and Heel, a pharmaceutical company specialized in developing and manufacturing medicines made from natural ingredients, have recently completed a series of research projects with a focus on improving exploratory preclinical studies. “We at Heel are pioneers in the field of systems research and have a […]

  • Zydus Cadila Seeks Approval to Commence P-III Clinical Study of ZyCoV-D

    Shots: The company reported that the COVID-19 vaccine is safe, well-tolerated & immunogenic in the P-I/II study & plans to initiate P-III clinical trial in ~30000 volunteers upon receiving necessary approvals The P-II study of ZyCoV-D had been conducted in ~1000 healthy adult volunteers as part of the adaptive P-I/II dose-escalation study The trial has […]

  • Regeneron’s Antibody Cocktail Demonstrate Promising Results in Hospitalized Patients on Low-Flow Oxygen

    Shots: The company reported encouraging initial data from an ongoing P-I/II/III trial of its casirivimab + imdevimab (8,000/2,400mg) in hospitalized COVID-19 patients requiring low-flow oxygen. The results passed the futility analysis as seronegative patients treated with the Ab cocktail had a lower risk of death or receiving mechanical ventilation In seronegative patients, the cocktail reduced […]

  • ViewPoints Interview: ViiV Healthcare’s Kimberly Smith Shares Insight on Data of Long-Acting Cabotegravir and Rilpivirine Presented at IDWeek 2020

    In a recent interview with PharmaShots, Kimberly Smith, MD, MPH, Head of Research & Development at ViiV Healthcare shared information on the positive findings presented at the 2020 Infectious Diseases Society of America (IDWeek) and the impact of COVID-19 on the development of long-acting cabotegravir and rilpivirine. Shots: The company reported the positive findings of […]

  • Cerner to snap up Kantar’s health division for $375M

    The EHR giant is planning to buy Kantar Health, which provides data, analytics and research to the life sciences industry. Through the acquisition, Cerner aims to provide its clients with more access to data analytics and research expertise and engagement with life sciences companies.

  • Roche Highlights its Bispecific Antibody Portfolio Across a Range of Blood Cancers at ASH 2020

    Shots: The company presented the new data of its T-cell engaging bispecific Abs, mosunetuzumab, glofitamab and cevostamab at ASH 2020, demonstrating encouraging activity across multiple types of blood cancer Roche divulges that its mosunetuzumab & glofitamab showed promising responses across multiple types of NHL, including R/R FL & DLBCL, reinforcing from the P-I/Ib GO29781 study […]

  • Dual Eligibles’ Medicaid Policy Database

    Poor, elderly individuals who may qualify for both Medicaid (for being poor) and Medicare (for being elderly, blind, disabled or have ESRD). In these cases, Medicaid serves as a supplemental insurer, covering Medicare coinsurance and deductibles. The generosity of this supplemental coverage for so-called ‘dual-eligibles’ varies across states. These differences in Medicaid payments arise from […]

  • Takeda to partner on patient-centric data with Seqster

    Takeda has partnered with patient data firm Seqster in a drive to improve care through better access and understanding of patient-level data. The partnership follows Takeda’s investment in the US startup earlier this year. The pharma firm said it wants to leverage the company’s technology across its business San Diego-based Seqster has developed a portal […]

  • Why 72% of patients don’t feel listened to by pharma

    Claus Møldrup explores research showing that patients want their voice to be heard more by pharma, and asks what a truly effective feedback loop for medicines might look like. The democratisation of data opens up improvements to virtually every product and service across virtually every sector — bar one. Pharma remains stubbornly closed to feedback, […]

  • What can we learn from women’s health data?

    Analysing real-world health data could help overcome the bias towards men in traditional medical research, says Sensyne Health’s Dr Lucy Mackillop. Collecting and analysing anonymised patient data has the potential to generate valuable insights that can catalyse research, lead to improved patient care, and power the development of new treatments. Being able to analyse large […]

  • Data hackathon analyses truth behind TB vaccine and COVID-19

    Is a century-old vaccine a ‘game-changer’ for COVID-19? Anita de Waard from Elsevier and Radoslav Kirkov from Estafet tells us how a hackathon is harnessing data science to look beyond the hype and seek definitive clinical evidence. Today, the notion of ‘data science’ has permeated almost every area of society. Words like machine learning, artificial […]

  • How real human experiences can power a healthier future

    As part of our series of opinion pieces from leaders at Janssen, the company’s Maria Raad looks at how we can embrace tech and data science to overcome increasing pressures on healthcare systems. For the next generation born in the western world, living to be the age of 100 will be the norm. While this […]

  • Rare diseases, repurposing and the role of AI

    In the age of artificial intelligence, no trial data should be going to waste. Findacure’s Rick Thompson looks at how these technologies could bring us closer to treatments for underserved rare diseases. The repurposing of drugs is becoming more common, especially in the field of rare diseases.  In the past, repurposing has mostly been driven […]

  • J+D FORECASTING LAUNCHES INTELLIGENT DATA

    J+D Forecasting, known as the experts in pharmaceutical forecasting, has today announced the launch of EpiCube; the latest addition to its comprehensive suite of pharmaceutical forecasting products. Unlike most standard epidemiological databases available, EpiCube is the first database where the user can choose how to build their own data set; be that by country, disease, […]

  • Pharma’s digital transformation journey and the role of customer reference data

    Better management of customer data could help pharmaceutical companies’ digital transformation, according to Veeva’s Rebecca Silver. pharmaphorum’s Richard Staines spoke to her about how the use of customer reference data can transform pharma companies, increase competitiveness, and benefit the bottom line during these challenging times. Precision medicine is emerging as a key approach for disease […]

  • The value of good data to patients

    Better patient care pathways and models of care can be leveraged from the use of data, and the ability to collate and assess this information will drive more sustainable models of care, whilst unlocking the value of ‘longitudinal, real-world data’ as a resource for healthcare organisations, research and academia, policy advisors and pharma. There is […]

  • COVID-19 is Bringing Data Privacy into the Spotlight – This is How Healthcare Companies Should Respond

    By DAN LINTON Privacy concerns across the country continue to increase, and consumers expect their healthcare information to be private. Headline-making data sales, skepticism of Silicon Valley privacy practices, and COVID-19 contact tracing concerns compounded with a general lack of consumer awareness have continued to generate an ongoing storm ofnegative press and political scrutiny. With COVID-19 continuing to rampage […]

  • CMS to penalize hospitals, labs that don’t report Covid-19 data

    New rules by the Center for Medicare and Medicaid Services would penalize hospitals and laboratories that report Covid-19 data. Hospitals would be required to report the number of confirmed or suspected Covid-19 patient, occupied beds, and availability of ventilators and other critical supplies.

  • Insights begin with clean, reusable data

    Good data practices lead to better research outcomes. To learn more about why clean, reusable data is critical to R&D, take a look at this helpful new infographic that demonstrates how Entellect is centered around the importance of reusable data, irrespective of scientific domain.

  • Next wave: how pharma analytics can be improved with new technologies

    Pharmaceutical companies have always had access to a steady stream of data to look at what has happened in the past and to try to predict future prescribing trends. Business intelligence (BI) departments have supported this throughout with timely and effective reporting, within an environment that has seen in recent years a bit of an […]

  • Brits more comfortable sharing data with pharma since COVID-19 – survey

    New research from MHP Health and ComRes looks at what impacts COVID-19 has had on the public’s health data sharing concerns, and asks how the industry can maintain confidence in data usage after the pandemic. In April, at the beginning of the COVID crisis, the Health Secretary Matt Hancock issued a six-month order for the […]

  • The Dawn of a European Health Data Space – Challenges

    The European data strategy aims to construct common data spaces for all, create a single EU market for data, and catalyze a dynamic data economy. In a previous post, we briefly described the essence of the envisioned heath data space and pointed at opportunities and possible starting points to transform this vision into reality. However, […]

  • The Dawn of a European Health Data Space – Opportunities

    At the beginning of 2020, the European Commission introduced a “European strategy for data.” The document proposes to bolster and advance the data economy in Europe with a view towards capturing “the benefits of better use of data, including greater productivity and competitive markets, but also improvements in health and well-being, environment, transparent governance and […]

  • Readying Your Workforce for Digital Transformation

    Seeing it as key to innovation and competitive advantage, many businesses in the life sciences are learning to embrace digital transformation these days—in fact, with good reason, most view it as necessary for survival. But whether or not the process of adopting rapidly-evolving digital-age technologies will actually result in business success can really depend on […]

  • The FAIR Toolkit Helps Researchers with Data Challenges

    Since the spread of COVID-19 was first reported, researchers of all types have mobilized to meet the challenges its causative agent, SARS-CoV-2, presents to the world. Data scientists in particular have been quick to apply their expertise to the problems of identifying, tracking and predicting outbreaks; diagnosing COVID-19; identifying infected individuals and detecting non-compliance with […]